Sue Kirsa

935 total citations
44 papers, 695 citations indexed

About

Sue Kirsa is a scholar working on Geriatrics and Gerontology, Occupational Therapy and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Sue Kirsa has authored 44 papers receiving a total of 695 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Geriatrics and Gerontology, 10 papers in Occupational Therapy and 10 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Sue Kirsa's work include Pharmaceutical Practices and Patient Outcomes (17 papers), Safe Handling of Antineoplastic Drugs (10 papers) and Pharmaceutical studies and practices (10 papers). Sue Kirsa is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (17 papers), Safe Handling of Antineoplastic Drugs (10 papers) and Pharmaceutical studies and practices (10 papers). Sue Kirsa collaborates with scholars based in Australia, United States and United Kingdom. Sue Kirsa's co-authors include Jim Siderov, Marliese Alexander, Senthil Lingaratnam, Linda Mileshkin, James D Mellor, Monica A. Slavin, Tony M. Korman, Jonathan Dartnell, Kate Burbury and Jeff Szer and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Antimicrobial Chemotherapy and BMJ Open.

In The Last Decade

Sue Kirsa

43 papers receiving 664 citations

Peers

Sue Kirsa

ONCOL

PPCH

EPIDE

Ahmed Al‐Jedai Saudi Arabia

Emily Mackler United States

Nancy A. Nickman United States

Prisca Olabisi Adejumo Nigeria

Dumessa Edessa Ethiopia

Ibtissam Khoudri Morocco

Marı́a Sillero-Arenas Spain

Matthias Paul HS Toh Singapore

Cristiano Soares de Moura Canada

Eric M. Tichy United States

Ahmed Al‐Jedai Saudi Arabia

Sue Kirsa

271 ×1.5

58 ×0.3

ONCOL

47 ×0.4

101 ×0.8

PPCH

157 ×1.4

EPIDE

Citations per year, relative to Sue Kirsa Sue Kirsa (= 1×) peers Ahmed Al‐Jedai

Countries citing papers authored by Sue Kirsa

Since Specialization

Citations

This map shows the geographic impact of Sue Kirsa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sue Kirsa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sue Kirsa more than expected).

Fields of papers citing papers by Sue Kirsa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sue Kirsa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sue Kirsa. The network helps show where Sue Kirsa may publish in the future.

Co-authorship network of co-authors of Sue Kirsa

This figure shows the co-authorship network connecting the top 25 collaborators of Sue Kirsa. A scholar is included among the top collaborators of Sue Kirsa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sue Kirsa. Sue Kirsa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abramson, Michael J., Billie Bonevski, Ashley Webb, et al.. (2024). Varenicline and Nicotine Replacement Therapy for Smokers Admitted to Hospitals. JAMA Network Open. 7(6). e2418120–e2418120. 1 indexed citations

Abramson, Michael J., Greg Weeks, Billie Bonevski, et al.. (2023). RCT Abstract - Varenicline and nicotine replacement therapy for smokers admitted to hospitals: a randomized, placebo-controlled trial. RCT4796–RCT4796. 1 indexed citations

Abramson, Michael J., Billie Bonevski, Michael Dooley, et al.. (2020). The efficacy and safety of varenicline alone versus in combination with nicotine lozenges for smoking cessation among hospitalised smokers (VANISH): study protocol for a randomised, placebo-controlled trial. BMJ Open. 10(10). e038184–e038184. 4 indexed citations

Hanna, Mary, et al.. (2018). Validation of a risk stratification tool for a Hospital Outreach Medication Review (HOMR) program. Research in Social and Administrative Pharmacy. 15(9). 1133–1137. 6 indexed citations

Alexander, Marliese, Robert Blum, Jenny Byrne, et al.. (2016). Guidelines for timely initiation of chemotherapy: a proposed framework for access to medical oncology and haematology cancer clinics and chemotherapy services. Internal Medicine Journal. 46(8). 964–969. 8 indexed citations

Jackson, SL, Grant Martín, Bronwyn Clark, et al.. (2015). Understanding advanced and extended professional practice. RMIT Research Repository (RMIT University Library). 76–79. 14 indexed citations

Jackson, SL, Grant Martín, Bronwyn Clark, et al.. (2015). Advanced practice: a survey of current perspectives of Australian pharmacists. Journal of Pharmacy Practice and Research. 45(2). 186–192. 8 indexed citations

Alexander, Marliese, Sue Kirsa, Rory Wolfe, et al.. (2014). Thromboembolism in lung cancer – An area of urgent unmet need. Lung Cancer. 84(3). 275–280. 29 indexed citations

Alexander, Marliese, Sue Kirsa, & James D Mellor. (2012). Thalidomide thromboprophylaxis in multiple myeloma: A review of current evidence. Asia-Pacific Journal of Clinical Oncology. 8(4). 319–324. 2 indexed citations

10.

Mellor, James D, et al.. (2012). Access to anticancer drugs: many evidence‐based treatments are off‐label and unfunded by the Pharmaceutical Benefits Scheme. Internal Medicine Journal. 42(11). 1224–1229. 20 indexed citations

11.

Lingaratnam, Senthil, Sue Kirsa, James D Mellor, et al.. (2011). A survey of reimbursement practices of private health insurance companies for pharmaceuticals not covered under the Pharmaceutical Benefits Scheme 2008. Australian Health Review. 35(2). 204–210. 1 indexed citations

12.

Lingaratnam, Senthil, Monica A. Slavin, Bogda Koczwara, et al.. (2011). Introduction to the Australian consensus guidelines for the management of neutropenic fever in adult cancer patients, 2010/2011. Internal Medicine Journal. 41(1b). 75–81. 29 indexed citations

13.

Lingaratnam, Senthil, Monica A. Slavin, Linda Mileshkin, et al.. (2011). An Australian survey of clinical practices in management of neutropenic fever in adult cancer patients 2009. Internal Medicine Journal. 41(1b). 110–120. 24 indexed citations

14.

Morrissey, C. O., Peter Bardy, Monica A. Slavin, et al.. (2008). Diagnostic and therapeutic approach to persistent or recurrent fevers of unknown origin in adult stem cell transplantation and haematological malignancy. Internal Medicine Journal. 38(6b). 477–495. 20 indexed citations

15.

Dickinson, Michael, H. Miles Prince, Sue Kirsa, et al.. (2008). Osteonecrosis of the jaw complicating bisphosphonate treatment for bone disease in multiple myeloma: an overview with recommendations for prevention and treatment. Internal Medicine Journal. 39(5). 304–316. 38 indexed citations

16.

Kirsa, Sue, et al.. (2002). Snapshot of Hospital Pharmacy Workforce in Australia. Journal of Pharmacy Practice and Research. 32(1). 72–76. 17 indexed citations

17.

Davis, Jill, et al.. (2001). Guidelines for Counselling Patients Receiving Drugs Used in the Treatment of Neoplastic Disease: a Pharmacist's Guide to Advisory Labels and Patient Information; The Society of Hospital Pharmacists of Australia Committee of Specialty Practice in Oncology. The Australian Journal of Hospital Pharmacy. 31(1). 51–55.

18.

Davis, Jill, et al.. (2000). SHPA Standards of Practice for the Transportation of Cytotoxic Drugs from Pharmacy Departments: The Society of Hospital Pharmacists of Australia Committee of Specialty Practice in Oncology. The Australian Journal of Hospital Pharmacy. 30(3). 116–117. 2 indexed citations

19.

Dartnell, Jonathan & Sue Kirsa. (2000). DUE‐An Essential Tool to Achieve QUM. The Australian Journal of Hospital Pharmacy. 30(6). 251–252. 2 indexed citations

20.

Davis, Jill, et al.. (1999). SHPA Standards of Practice for the Safe Handling of Cytotoxic Drugs in Pharmacy Departments: The Society of Hospital Pharmacists of Australia Committee of Specialty Practice in Oncology. The Australian Journal of Hospital Pharmacy. 29(2). 108–116. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact